About Tetra Bio-Pharma
Tetra Bio-Pharma is a company based in Ottawa (Canada) founded in 2015 by Andre Audet.. Tetra Bio-Pharma has completed 1 acquisition, including Panag Pharma. Tetra Bio-Pharma operates in a competitive market with competitors including Flexion Therapeutics, Eliem Therapeutics, Zogenix, Nuvalent and Enliven Therapeutics, among others.
- Headquarter Ottawa, Canada
- Founders Andre Audet
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tetra Bio-Pharma Inc.
-
Annual Revenue
-
Net Profit
$-40.81 M-98.88as on Nov 30, 2021
-
EBITDA
$-18.91 M-19.99as on Nov 30, 2021
-
Latest Funding Round
-
Investors
Aphria
& 4 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Tetra Bio-Pharma
Tetra Bio-Pharma is a publicly listed company on the OTC with ticker symbol TBPMQ in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Tetra Bio-Pharma
- Total Funding Total Funding
- Total Rounds 10
- Last Round Last Round
-
First Round
First Round
(27 Mar 2018)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Grant - Tetra Bio-Pharma | Valuation |
investors |
|
| Aug, 2022 | Amount | Post-IPO - Tetra Bio-Pharma | Valuation |
investors |
|
| May, 2022 | Amount | Post-IPO - Tetra Bio-Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tetra Bio-Pharma
Tetra Bio-Pharma has secured backing from 5 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Aphria, National Research Council Canada and Cannvalate. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Scientific and technological research is conducted for Canada's benefit.
|
Founded Year | Domain | Location | |
|
Cannabis-based products and services are manufactured and supplied.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tetra Bio-Pharma
Tetra Bio-Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Panag Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cannabinoid-based formulations are developed for pain and inflammation treatment.
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Tetra Bio-Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tetra Bio-Pharma Comparisons
Competitors of Tetra Bio-Pharma
Tetra Bio-Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Eliem Therapeutics, Zogenix, Nuvalent and Enliven Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for cancer, including NSCLC inhibitors, are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for solid tumours and blood cancers
|
|
| domain | founded_year | HQ Location |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tetra Bio-Pharma
Frequently Asked Questions about Tetra Bio-Pharma
When was Tetra Bio-Pharma founded?
Tetra Bio-Pharma was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Where is Tetra Bio-Pharma located?
Tetra Bio-Pharma is headquartered in Ottawa, Canada. It is registered at Ottawa, Ontario, Canada.
Who is the current CEO of Tetra Bio-Pharma?
Guy Chamberland is the current CEO of Tetra Bio-Pharma.
What does Tetra Bio-Pharma do?
Developer of natural medicinal plant-based elements for treating multiple diseases. It engaged in the development of biopharmaceuticals and natural health products containing Cannabis and other medicinal plant-based elements. Its drug pipeline includes PPP001, a smokable bio-cannabis pharmaceutical for chronic pain, PPP002 to treat Insomnia, and PTSD in chronic pain patients, and PPP003 for chronic pain, PTSD, and other neurologic and psychiatric conditions. The company also develops natural health products for skin care, pain management, etc.
Who are the top competitors of Tetra Bio-Pharma?
Tetra Bio-Pharma's top competitors include Flexion Therapeutics, Nuvalent and Enliven Therapeutics.
Is Tetra Bio-Pharma publicly traded?
Yes, Tetra Bio-Pharma is publicly traded on OTC under the ticker symbol TBPMQ.
How many acquisitions has Tetra Bio-Pharma made?
Tetra Bio-Pharma has made 1 acquisition, including Panag Pharma.
Who are Tetra Bio-Pharma's investors?
Tetra Bio-Pharma has 5 investors. Key investors include Aphria, National Research Council Canada, Cannvalate, Alpha Blue Ocean, and Michael Nashat.
What is Tetra Bio-Pharma's ticker symbol?
The ticker symbol of Tetra Bio-Pharma is TBPMQ on OTC.